2011
DOI: 10.1097/aog.0b013e318202c845
|View full text |Cite
|
Sign up to set email alerts
|

Postpartum Hemorrhage Resulting From Uterine Atony After Vaginal Delivery

Abstract: II.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

8
149
3
8

Year Published

2011
2011
2023
2023

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 166 publications
(172 citation statements)
references
References 15 publications
8
149
3
8
Order By: Relevance
“…Oxytocin is commonly used to maintain uterine contractility during labor and to stop bleeding after delivery [17]. However, similar to our finding, previous studies have reported the association of labor augmentation with oxytocin and severe PPH [16]. Desensitization of the oxytocin receptor to the uterotonic effects of oxytocin has been suggested to be the underlying cause [18].…”
Section: Discussionsupporting
confidence: 87%
See 1 more Smart Citation
“…Oxytocin is commonly used to maintain uterine contractility during labor and to stop bleeding after delivery [17]. However, similar to our finding, previous studies have reported the association of labor augmentation with oxytocin and severe PPH [16]. Desensitization of the oxytocin receptor to the uterotonic effects of oxytocin has been suggested to be the underlying cause [18].…”
Section: Discussionsupporting
confidence: 87%
“…Additionally, as demonstrated in this study, atony is also the leading etiology of severe PPH. The oxytocin augmentation and prolonged labor, which are the independent predictors for severe PPH, were also known to be risk factors for uterine atony [16]. Oxytocin is commonly used to maintain uterine contractility during labor and to stop bleeding after delivery [17].…”
Section: Discussionmentioning
confidence: 99%
“…uterine artery embolization and/or haemostatic surgery, are recommended, unfortunately there is no unequivocal evidence as to when, or based on what parameters, a more invasive therapy should be initiated [13]. This lack of ''accepted'' (and easily measurable bed-side) parameters indicating the failure of conservative therapy and the need for an AIP, has undoubtedly led in many cases to delays in initiation of aggressive therapy and/or transfer to a specialized tertiary care centre, and it has been proven that delay in initial care is an independent predictor of severe blood loss in women with PPH [14].…”
Section: Introductionmentioning
confidence: 99%
“…Compte tenu des faibles connaissances que nous avons en termes de dose optimale et d'effets secondaires, l'administration prophylactique ne pourrait être conseillé e que chez les patientes à haut risque d'hé morragie du post-partum, tenant compte de critè res validé s dans la litté rature (ané mie pendant la grossesse, anté cé dent d'hé morragie du post-partum, anomalie de placentation) [41][42][43].…”
Section: Discussionunclassified